| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |